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Chapter
Distribution and Molecular 
Detection of Methicilin-Resistant 
Staphylococcus aureus
Velma Rebić, Mufida Aljičević, Sajra Vinčević-Smajlović  
and Damir Rebić
Abstract
Isolation of Staphylococcus aureus is quite common in both the general population 
and hospital environment. The heterogeneity of the disease and the unique ability 
of S. aureus to develop resistance to the most recently discovered antibacterial drugs 
points to its ability to adapt and survive in different conditions. CA-MRSA is differ-
ent from hospital strains of MRSA by its epidemiological, phenotypic and genotypic 
characteristics. The emergence of MRSA in the community suggests the need for a 
new approach to managing the indications and the certification of staphylococcal 
infections, with special emphasis on the selection of empiric antibiotic therapy. 
In the study, we analised of MRSA from 4341 samples taken from patients from 
the general population of Sarajevo Canton in the six-month period of follow-up 
processed at the Public Health Institute of Sarajevo Canton. We determined the 
epidemiological characteristics of the isolated strains. Methicillin resistance was 
determined by phenotypic methods. The following molecular methods were used 
for the confirmation of methicillin resistance: determination of the mecA gene, 
PFGE profile, genetic type of MRSA being determined by spa typing, the distribu-
tion of SCCmec types being examined, and the detected gene for PVL. The study 
stresses the need for national monitoring of spreading of the existing epidemic 
strains, as well as the monitoring of emergence of new strains which would enable 
the inclusion of our country in the international network of monitoring bacterial 
resistance.
Keywords: infection, CA-MRSA, phenotypic, antimicrobial susceptibility
1. Introduction
The first isolation of Staphylococci was carried out by Alexander Ogston during 
the investigation of the septicemia and wound infection bacteria in 1880, the 
microscopical examination of 88 pus specimens revealed the presence of Gram-
positive cocci (S. aureus) [1]. In clinical observations, the most important species 
of Staphylococcus genus are Staphylococcus aureus and Staphylococcus epidermids, 
further falling into categories based on their coagulase activity. S. aureus is coagu-
lase positive, expressing several virulence factors supporting host immune response 
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evasion. S. epidermidis being coagulase negative, usually less virulent, able to avoid 
the host immune system by forming and resulting in its hiding in a biofilm [2]. 
Staphylococcus aureus (SA) represents one of the most important microorganisms 
that are part of the normal micro flora in humans, with ability to cause very seri-
ous infections in certain conditions. Approximately 20–30% of the general human 
population is persistently colonized with SA. Primary and natural reservoir of 
S. aureus is the asymptomatic carriage by humans, using the anterior nasal mucosa 
as the main ecological niche. The risk of subsequent infection increases as the 
colonization provides a reservoir open to bacteria introduction as host defences 
are breached [3]. Adding to humans and domestic animals, livestock and fomites 
can also serve as joint reservoirs, providing this bacterial pathogen with dramatic 
relevance in human and veterinary medicine. Staphylococcus aureus can cause a 
wide variety of infections in range from common, mild skin and soft tissue infec-
tions to hematogenous infections with multi organ injuries. Staphylococcus aureus 
is infamous for its ability to become resistant to antibiotics, resulting in issues with 
treatment of these infections due to the resistance development, especially with 
methicillin-resistant SA [4]. The virulence of S. aureus is multifactorial due to the 
combined actions of a variety of virulence factors that facilitate tissue adhesion, 
immune evasion, and host cell injury [5]. These virulence factors involve both 
structural, such as surface adhesins which provide adherence to host tissues, and 
secreted factors, such as enzymes, that convert host tissue into nutrients. Anyway, 
a lot more significant is the secretion of a variety of pyrogenic toxins also known as 
superantigens; the Panton–Valentine leukocidin (PVL) and toxic shock syndrome 
toxin-1 (TSST-1) as most remarkable [6].
1.1 Methicillin-resistant Staphylococcus aureus
Methicillin-Resistant Staphylococcus aureus (MRSA) should be taken into 
accounted for great concern. It is the cause of bacterium infections in various parts 
of body. As it develops resistance to usually prescribed antibiotics, its treatments 
becomes more difficult than with most strains of Staphylococcus aureus. MRSA is 
sometimes called a super bug. Methicillin-resistant Staphylococcus aureus (MRSA), 
or multidrug-resistant S. aureus, first described in the United Kingdom in the early 
1960s, are S. aureus strains which developed resistance through natural selection 
process to all available penicillins and other β-lactam antimicrobial drugs. Methicillin 
resistant Staphylococcus aureus (MRSA) being one of the most important hospital 
pathogens, becomes responsible for community infection in patients without previ-
ous health-care contact at the end of the last century. Worldwide, it is mainly respon-
sible for a broad spectrum of nosocomial and community associated infections and 
cause of endemic and epidemic infections in many parts of the world. Methicillin 
resistance in S.aureus developed through the acquisition of the mecA gene located 
on mobile genomic island designated staphylococcal chromosome cassette mec 
(SCCmec) by methicillin-susceptible S.aureus [7]. The mecA gene is primary cause 
for the synthesis of a novel penicillin-binding protein known as penicillin-binding 
protein 2a, that decreased binding affinity for penicillin and cephalosporins. It 
follows that MRSA strains are resistant to all ß-lactam antibiotics. In the beginning, 
MRSA was susceptible to nonbeta lactam antibiotics. Later, namely, from the late 
1979s to this day, new strains of MRSA resistant to multi-non- ß-lactam agents 
including aminoglycosides, with only vancomycin left as an antibiotic of last resort 
for treating MRSA infections, appeared. These strains, also described as epidemic 
MRSA (EMRSA or HA-MRSA), have had the capacity to spread extensively causing 
serious infections worldwide and mostly among in-hospital patients [8].
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1.2 What is community-associated MRSA?
During 1990s, in Western Australia, a new MRSA type appeared and it was 
causing infections in the community of younger and healthy people without 
previously reported history of hospital admission or medical treatment [9]. These 
types of MRSA strains were described as community-acquired, community-
originated, community-associated, or community-onset MRSA (CA-MRSA). 
HA-MRSA and CA-MRSA belong to different genetic lineages. While CA-MRSA 
strains are usually sensitive to antibiotics other than beta-lactams and contain 
staphylococcal cassette chromosome SCCmec type IV, V or VII, HAMRSA are gen-
erally multidrug-resistant and harbour larger SCCmec type I, II or III [10]. MRSA 
pathogenicity is related to extensive arsenal of virulence factors and toxins. The 
most common and probably important is the Panton-Valentine leukocidin (PVL) 
toxin being lethal to neutrophils and associated with skin and soft tissue infec-
tions as well as severe necrotizing pneumonia. Huge number of CA-MRSA clones 
have developed on every continent [11]. Notably, these CA-MRSA strains, initially, 
were associated with community-onset (CO) infections, have been entering 
hospitals and may be replacing the conventional HA-MRSA strains with signifi-
cant clinical and public health implications [12]. However, CA-MRSA penetration 
is still mostly undefined due to lack of thorough exploration of in large number of 
hospitals as well as knowledge of the risk factors involved in nosocomial trans-
mission of CA-MRSA compared with HA-MRSA [13]. The prevalence of in vitro 
resistance to non-β-lactam antimicrobial agents could be increasing among MRSA 
strains related to community transmission. MRSA typing is an essential com-
ponent of an overall follow up system of describing epidemiological trends and 
control strategies for infections. Contemporary challenges for MRSA typing are 
focused on choosing the most appropriate technique in terms of efficiency, reli-
ability, ease of performance and cost included. The phenotypic methods in general 
are prone easier performance, interpretation, cost efficiency and wide availability, 
and less discrimination. The genotypic methods are rather expensive and techni-
cally demanding, however more discriminatory. Latest technologies that involve 
sequencing of various genes are emerging as highly applicable with wide through-
put typing systems. Still there is no consensus regarding the single best method for 
typing of MRSA strains [14]. Pulsed-field gel electrophoresis (PFGE) has become 
the ‘gold standard’ for genotyping method of MRSA for over a decade, and it 
has been used widely for local outbreak investigation, long-term surveillance of 
MRSA infections at regional and national levels and for international comparisons 
[7]. Recently, in Europe, harmonization efforts to standardize the PFGE typing 
protocol of MRSA as well as to enable multicentric comparison of PFGE data have 
been made. The macro restriction analysis of chromosomal DNA using PFGE is a 
reference method for Staphylococcus aureus typing and can be combined with other 
methods [15].
1.3 Detection and diagnosis of MRSA strains
Identifying the causative organism can be challenging in treatment 
Staphylococcus aureus infection, especially for resistant strains. Traditional culture 
and susceptibility testing for MRSA lasts between 48 and 72 h, taking a 16- to 
24-h incubation and 16 to 24 h more in completing the susceptibility tests. Latest 
progress in molecular and nonmolecular testing methods greatly reduced the time 
needed to detect MRSA [16]. These rapid and sensitive screening assays could 
contribute to infection control and reducing overall costs. With a rapid test,  
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Bauer et al. [17] observed bacteremia patients diagnosed with MRSA had a shorter 
length of stay and lower hospital costs, and for patients with MSSA, the switch 
from empiric to targeted therapy was 1.6 days shorter. Use of rapid molecular 
diagnostic tests rather than conventional methods is also related to a significantly 
lower mortality risk for patients with bloodstream infections (odds ratio (OR) 
[95% CI] 0.66 [0.54–0.80]), including those caused by Gram-positive organisms 
(OR [95% CI] 0.73 [0.55–0.97]). Combining rapid molecular testing with an antibi-
otic stewardship program will be able to lower the mortality risk [18]. Individual 
hospitals in decision making about the tests used should consider the specificity, 
sensitivity, price, turnaround time, and expertise, necessary for each test [16, 19]. 
Modification to the traditional culture method is the use of chromogenic agar, 
producing a colour reaction in the bacterial cultures. These media also contain 
antibiotics where only resistant bacteria is able to grow. According to this, MRSA 
can be detected in 20 to 26 h [16]. In clinical practice, the use of chromogenic media 
has been seen to shorten the time to aimed MRSA treatment by 12 h [20]. Another 
innovation in MRSA detection is the development of real-time polymerase chain 
reaction (PCR) tests with the ability to detect genes specific to S. aureus. In making 
difference in MRSA strains from MSSA or methicillin resistant coagulase-negative 
staphylococci, PCR methods are aimed at a part of DNA where the MRSA-specific 
SCCmec gene meets the S. aureus orfX gene. The PCR tests are usually performed 
directly on samples taken from blood or a nasal or wound swab, and results can be 
available within 1 to 3 h [16]. In clinical practice, generally, the turnaround times 
from taking samples to complete results are generally longer due to the length of 
time needed to transport samples, conduct the test, and send the results. As a rule, 
the overall time is usually much shorter with PCR-based assays than with chromo-
genic media culture [21]. Moreover, PCR tests showed pooled estimates for sensi-
tivity and specificity of 92.5 and 97.0%, respectively, in the meta-analysis described 
earlier. In addition, the sensitivity of PCR has been notably higher than the one on 
chromogenic media, and the specificity was significantly higher than the one on 
traditional culture [19]. In relation to MRSA detection by chromogenic agar, PCR 
shortened the overall time of patient isolation as well as number of days patients 
were inadequately isolated during their hospital stay [21].
2. Aims
• To determine the prevalence and distribution of methicillin-resistant 
Staphylococcus aureus from different patient samples in general population of 
Canton Sarajevo, Bosnia and Herzegovina
• To determine epidemiological characteristics of isolated strains
• To evaluate isolated MRSA with phenotypic methods: disc diffusion test (DD), 
E-test, latex agglutination test with antibodies to penicillin-binding protein 2a 
(PBP2a), and a selective chromogenic medium
• To determine the presence of mecA gene in isolated outpatient strains
• To determine the genetic profile of MRSA strains by DNA Fingerprints by 
Pulsed-field Gel Electrophoresis (PFGE) and spa-typing test methods
• To evaluate the distribution of SCCmec types
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• To determine the prevalence of Panton-Valentine leukocidin (PVL) -positive 
Staphylococcus aureus strains
• To estimate infection and colonization risk of outpatient MRSA strains
3. Materials and methods
Samples taken from January to August 2015 were collected from 4,341 patient 
samples admitted to the Laboratory of Institute of Public Health of Sarajevo 
Canton, Bosnia and Herzegovina (B&H) and they showed a total number of 653 
methicillin-resistant Staphylococcus aureus, that is, out of 2279 found Staphylococcus 
aureus strains, 653 were methicillin-resistant Staphylococcus aureus. Those samples 
included nose swabs, throat, ear, eye, umbilicus swabs, wound and skin swabs. 
All MRSA isolates collected were identified by standard microbiological methods 
based on the demonstration of deoxyribonuclease, bound coagulase (rabbit 
plasma, bioMerieux, France) and free coagulase (Slidex Staph Plus, bioMerieux, 
France) [22]. Antibiotic susceptibility determination used the agar disk diffusion 
method in compliance with the guidelines of the Clinical Laboratory Standards 
Institute [23, 24]. The following twelve antibiotics were tested to the susceptibil-
ity of the S. aureus isolates: sulfamethoxazole-trimethoprim, oxacillin, cefoxitin, 
erythromycin, clindamycin, linezolid, ciprofloxacin, tetracycline, fusidic acid, 
rifampicin, vancomycin and gentamicin. Multiplex PCR was used for testing 
those MRSA strains for the presence of the mecA gene. Molecular analysis of 
the SCCmec cassette was conducted using a method earlier depicted by Oliveira 
et al. [25], with certain modification indicated by Budimir et al. [26]. Presence of 
the gene for PVL was found by use of PCR primers previously accounted for by 
Lina et al. [27]. In addition, all of these isolates passed analysis for epidemiologi-
cal relatedness by pulsed-field gel electrophoresis (PFGE). Macrorestriction of 
chromosomal DNA used the restriction enzyme SmaI analysis, complying with 
previously described procedure. DNA fragments were separated using a CHEF-DR 
III electrophoresis system (Bio-Rad laboratories, Hercules, California, USA) at 
6.0 V/cm for 2O h, with pulse times ramped from 5 s to 40 s. Gels used with ethid-
ium bromide staining and they were photographed under UV illumination. PFGE 
patterns analysis was done by using GelCompare software (Applied Maths, Ghent, 
Belgium) according to the Tenover et al. scheme [28]. Isolates with indistinguish-
able band patterns were assigned to the same PFGE pattern type. Isolates that 
differed by ≤ three fragments were considered to be subtypes closely related i.e. 
of a given clonal group. The dendrogram was produced by use of 0, 5% optimiza-
tion, a 3% band tolerance and the unweighted pair group method with arithmetic 
averages based on Dice coefficients.
4. Results
Out of the total number of isolates, the largest number of isolates included in 
our research was isolated from the nasal or nasopharyngeal swab (41%), while 35% 
isolates were found in a skin swab samples. There was 1% isolates isolated from the 
umbilical swab and sputum sample, and 2% from an abscess puncture sample and 
conjuctival swab.
Based on the analysis of data from the epidemiological questionnaire, we 
estimated the distribution of examinees by gender. Out of a total of 100 subjects 
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included in the study, 49 (49%) were male and 51 (51%) female and there was no 
statistically significant difference in the percentage of the particular sex. The aver-
age age of the respondents was 10.9 ± 18.7 years.
Prior to the start of the study, 59% of subjects had hospital treatment according 
to the anamnestic data, but there was no statistically significant difference in the 
groups with and without hospital treatment in the year before the start of this study. 
Out of the 59 examinees who were hospitalized, 86.4% were hospitalized in the 
maternity hospital, while a significantly smaller number was hospitalized in ortho-
pedics (5.1%), pediatrics (3.4%), dermatology, gynecology and surgery (1.7%).
Antibiotic usage within 12 months before the follow-up period was recorded in 32% 
of examinees, while 68% of them did not recieve therapy in that period, which is sta-
tistically significant. Out of the group of examinees who were taking antibiotics, 34.4% 
recieved amoxicillin and clavulanic acid, 18.8% recieved fourth-generation cephalo-
sporins and sulfethoxazole-trimethoprim, while only 6.3% recieved macrolides.
MRSA was present in only 3% examinees out of those who had previosly docu-
mented MRSA strains (one year before this study). 6.0% of examinees included in 
the study had surgical procedure at the same time, while 94% of examinees didn’t 
have surgery.
Epidemiological data are a significant variable for differentiating CA and HA 
MRSA. Therefore, variables that may have influenced the transmission and devel-
opment of staphylococcal infections have been included in the epidemiological 
questionnaire. None of the subjects had been on dialysis therapy, nor had they been 
placed in a nursing home for 12 months prior to our study. 10% of examinees stated 
that they own a pet (80% own a dog as a pet and 20% a cat as a pet).
Out of total number of examinees, 8.0% of examinees had previous contact with 
a MRSA infected patients, 13% were involved in sports and 2.0% of examinees used 
an invasive /orthopedic device.
4.1 Microbiological analysis of the strains
During the follow-up period, out of a total of 4341 examined patient samples, 
2279 Staphylococcus aureus were isolated, out of which 653 were methicillin-resistant 
SA. The prevalence of Staphylococcus aureus was 52.5% and the prevalence of MRSA 
was 28.7%.
We selected a representative sample of 100 strains, eliminating the “copy” 
strains (strains from the same patient at different places and those that are 
repeated), by random selection, trying to monitor the dynamics and even represen-
tation throughout the months of the study period).
4.2 Results of antibiotic susceptibility testing
In our study, 100 strains were tested for susceptibility to 12 antibiotics. 
Antibiotics that were tested include antibiotics that are therapeutically important 
for staphylococci, as well as other antibiotics that are known to be resistant to them 
as a marker for a virulent clone, such as fusidic acid.
All MRSA isolates were resistant to the β-lactam antibiotics tested, i.e. penicillin, 
oxacillin, and cefoxitin, 68% of MRSA strains were resistant to erythromycin, 5% 
to clindamycin, 5% to gentamicin and 4% to ciprofloxacin. All isolates were suscep-
tible to sulphamethoxazole-trimethoprim, rifampicin, fusidic acid, linezolid and 
vancomycin (Table 1).
Based on the antibiogram, all examined strains were divided into 5 profile 
groups. Group A was represented in 32%, group B in 62%, group C 4%, group D 1% 
and 1% group E. (Table 2).
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4.3 Results of phenotypic methods in MRSA detection
In our study, conventional phenotypic methods were used to detect MRSA 
isolates: disk diffusion oxacilin test and disk diffusion cefoxitin test. To confirm 
the MRSA isolates, a latex agglutination test with antibodies to PBP2a, a selective 
chromogenic medium, ChromID MRSA, and an E test were used to determine the 
value of the minimum inhibitory concentration for oxacillin.
Oxacillin disk diffusion and cefoxitin disk diffusion tests, due to their accuracy 
and economic acceptability, have proven to be good options for the detection 
methicillin resistance of S.aureus. The results of this study indicate a previously 
proven fact that the latex agglutination test, ChromID MRSA, and E test, due to 
their high sensitivity and specificity, play a significant role as confirmatory tests for 
the detection of methicillin resistance.
All phenotypic methods that were used had 100% sensitivity as well as  
specificity, except for the DD cefoxitin and DD oxacillin tests, 98.9 and 96.8.
Resistant Sensitive
Penicillin 100 (100%) 0
Oxacillin 100 (100%) 0
Cefoxitin 100 (100%) 0
Erythromycin 68 (68%) 32 (32%)
Clindamycin 5 (5%) 95 (95%)
Sulphamethoxazole- trimethoprim 0 100 (100%)
Rifampicin 0 100 (100%)
Fusidic acid 0 100 (100%)
Gentamicin 5 (5%) 95 (95%)
Ciprofloxacin 4 (4%) 96 (96%)
Linezolid 0 100 (100%)
Vankomycin 0 100 (100%)
Table 1. 
Antimicrobial susceptibility patterns (N = 100).
Groups Profile groups
A resistant to penicillin, oxacillin and cefoxitin; sensitive to erythromycin, clindamycin, 
sulphamethoxazole-trimethoprim, rifampicin, fusidic acid, garamycin, ciprofloxacin, linezolid and 
vancomycin
B resistant to penicillin, oxacillin, cefoxitin and erythromycin; sensitive to clindamycin, 
sulphamethoxazole-trimethoprim, rifampicin, fusidic acid, garamycin, ciprofloxacin, linezolid and 
vancomycin
C resistant to penicillin, oxacillin, cefoxitin, erythromycin, clindamycin, garamycin, ciprofloxacin; 
sensitive to sulphamethoxazole-trimethoprim, rifampicin, fusidic acid, linezolid and vancomycin
D resistant to penicillin, oxacillin, cefoxitin, erythromycin, clindamycin; sensitive to 
sulphamethoxazole-trimethoprim, rifampicin, fusidic acid, garamycin, ciprofloxacin, linezolid and 
vancomycin
E resistant to penicillin, oxacillin, cefoxitin, and garamycin; sensitive to erythromycin, clindamycin, 
sulphamethoxazole-trimethoprim, rifampicin, fusidic acid,ciprofoxacin, linezolid and vancomycin
Table 2. 
Profile groups based on the antibiogram.
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4.4 Molecular analysis of tested strains
4.4.1 MecA gene detection
Reduced sensitivity or resistance to oxacillin or cefoxitin was found in all iso-
lates, including the study by phenotypic methods. After detection of MRSA isolates 
by phenotypic methods, all isolates were subjected to molecular methods that tested 
the presence of the mecA gene.
All tested isolates were positive for the mecA gene. The control mecA positive 
strains used in our study are MRSA isolates described in the Methods section. One 
of the isolates used is COL and the other is WIS.
COL is an MRSA strain isolated for the first time in 1965 in Great Britain, known 
as a representative of the Archaic clone, whose characteristics are: SCCmec type I, 
ccr AB 1, sequential type (ST) 4.
WIS is an MRSA isolate native to Australia, SCCmec type V, possesses ccrC.
4.4.2 Spa-typing test results
As previously described in the Introduction to Spa Typing, the polymorphic 
region X consists of a variable number of 24 base pairs of repeating fragments. 
From a total of 100 strains examined, we selected a representative sample of 
29 strains that underwent spa-typing. Seven different spa types were discovered: 
t008, t919, t041, t1179, t2187, t2674 and t10807. The most common type was t008 
(55.2%).
4.4.3 SCCmec typing
We analysed and subjected 100 isolates to SCCmec typing. The obtained amplifi-
cation products differ in molecular weight, and the typing result is obtained by visual 
comparison with the control strains. SCCmec loci of control strains were also ampli-
fied in each reaction cycle. A marker was applied to each individual gel, with a range 
of DNA fragments of 100-1500pb. The PCR products of the control strains were elec-
trophoretically parallel separated. Each amplification cycle in which no corresponding 
PCR product was obtained in the control strains was repeated, as well as PCR reac-
tions and electrophoresis of isolates that could not be typed with this method.
The distribution of SCCmec types is shown in Figure 1. The most prevalent 
SCCmec element was type IV (86%), followed by SCCmec I (4%) and SCCmec type 
Figure 1. 
SCCmec types distribution among MRSA isolates. Note: NT- non-typeable.
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V (1%). Non-typical strains were found in 9.0% of cases. No isolates with SCCmec 
III were found during this analysis. Chi-square test was used for the analysis of 
categorical variables.
4.4.4 Determination of the presence of the PVL gene
Using the primers and amplification cycle conditions described in the Method 
section, 100 isolates were tested for the presence of the PVL toxin gene. MW2 
strain, MRSA strain isolated in 1998 in the USA, SCCmec type IV, ST131 was used as 
a positive control strain.
Positive expression of PVL gene was found in 24.0% of isolates, while 76% 
showed a statistically significant higher negative expression of PVL gene.
The current prevalence of CA MRSA PVL positive isolates was 0.05% and the 
periodic prevalence was 0.037%.
Common to all positive PVL MRSA isolates is SCCmec type IV and the fact that 
they are outpatient isolates.
4.4.5 Results of PFGE analysis
Results PFGE - electrophoretic profiles of isolates.
Pulsed field electrophoresis after the splitting of chromosomal DNA by the 
restriction enzyme SmaI yielded clearly separated DNA fragments that were visual-
ized by UV light illumination after staining with ethidium bromide and photo-
graphed with a Polaroid camera.
Figure 2 shows a photograph of electrophoretic gels that are part of the results 
obtained by this analysis. The number of fragments greater than 10 for each isolate 
is visible, the minimum of the bands to which the comparison standards described 
in the Methods section can be applied. Figure 2 is a representation of a PFGE 
electrophoretic gel after cleavage with SmaI enzyme and separation in an electric 
field and staining with ethidium bromide.
M means a lambda marker, and genotyped strains are numbered 1–20. Blank 
fields 7 and 12 mean that the isolation probably failed in the first attempt and we 
repeated these isolates.
Figure 2. 
Representative PFGE patterns of MRSA strains isolated from population included in the study, after splitting 
enzyme SmaI and separation in an electric field and staining with ethidium bromide.
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Determination of PFGE groups using dendrogram percentage similarity:
The photos were scanned and stored in the database of the computer software 
system GelCompar. Each individual strip was subjected to a normalization pro-
cedure, in which, for each individual photograph, the size of the fragments was 
compared with the same molecular standard found on each gel in the electropho-
retic reaction.
After normalization and entering basic data into the database, a dendrogram 
of similarity percentage was made, using Dice coefficient from PFGE data, using 
a limit value of ≥80%, with a tape tolerance of 3% and an optimization parameter 
of 0.5%.
In the PFGE profile analysis of the isolates with the computer system 
GelCompar, the isolates fell into five similarity groups: A-E. The largest number of 
isolates (87%) belonged to one of two groups: C (60%) and D (27%).
Group A includes 3 isolates, described as SCCmec type IV. There were no PVL 
positive isolates in this group.
Group B included four isolates, with three isolates being SCCmec type I, while 
one was SCCmec type IV. There were no PVL positive isolates in this group.
Group C represents the largest group in the PFGE analysis, including 60 isolates, 
and all isolates of this group belonging to SCCmec type IV. In this group, 28.33% 
(17) of isolates were PVL positive.
Group D includes 27 isolates, three of which were nontypeable, and the rest of 
the isolates belong to SCCmec type IV. In this group, only two isolates were PVL 
positive.
Group E included 3 isolates, SCCmec types I, IV and V. These three isolates were 
not PVL positive.
Three PFGE types were singletons, that is, not similar to any of the other strains, 
two of which are SCCmec IV, while one is nontypeable.
5. Discussion
Staphylococcus aureus is one of the most important and adaptable human patho-
gens, causing most often skin and soft tissue infections, although it can cause any 
organ and organic system infection as well as infections related to toxin production 
[29]. Colonisation is important step in pathogenesis of infections caused by S. 
aureus. Approximately 20–30% of overall population is persistently colonised by 
S. aureus, with verified colonisation at nasal mucosa [30]. This study microbiologi-
cally analyses 4341 different biological specimens from out of hospital respondents. 
Staphylococcus aureus is isolated in 2279 specimens, with prevalence of 52,5%. Out 
of 2279 identified Staphylococcus aureus, methicillin resistance was shown in 653 
isolates proved by use of phenotype methods, thus MRSA prevalence was 28,7%. 
Considering the use of MRSA prevalence as an indicator of success in conducting 
infection control programme, there are series of data from various geographi-
cal areas that point to high variability of MRSA prevalence in the whole world. 
European research show high variability in MRSA prevalence results. Thus, per-
centage of MRSA in Scandinavian countries and Netherlands is less than 1%, while 
prevalence in Spain is more than 50% [31]. At latest, growth of bacterial isolates 
number resistant to methicillin becomes serious clinical and epidemiological 
problem. Introducing methicillin into clinical practice in 1961, MRSA soon becomes 
one of the main intra-hospital problems around the world. Nowadays, MRSA still 
holds primate in hospital environment, and in the last few years in out of hospital 
environments as well. Namely, in the nineties of the last century, the problem of 
out of hospital MRSA (Community-acquired methicillin-resistant Staphylococcus 
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aureus or CA-MRSA) arises, in many features different from hospital MRSA strains. 
Staphylococcus aureus resistant to methicillin is placed highly in modern microbiol-
ogy and infection control procedures. Recent studies show change in microbiology 
of MRSA as well as its limitation to hospital environment so the infection can 
appear in general population [29]. CA-MRSA strains become important health issue 
connected with high morbidity and mortality in general population [32].
In our study, we selected representative sample of 100 MRSA strains, eliminating 
“copy” strains (strains of the same patient from different places and those repeated 
ones), by random choice method, trying to follow the dynamics and equal represen-
tation through individual months of research period. In our study, 41% cases con-
firmed presence of the pathogen in the nasal, and 35% samples isolated S.aureus in 
skin smear. Creech et al. confirmed colonisation of nasal mucosa in paediatric cases 
with S.aureus in 35% cases, and in 9% cases they bore nasal MRSA [33]. Male sex 
was positive to MRSA in 49%, while females were positive in 51% of analysed MRSA 
specimens. In Farr et al. study [34] has shown that females were highly represented 
in verified CA-MRSA infections. The same study shows the greatest number of out of 
hospital infections in females aged 18–44. In our study average age was 10,9 (±18,7). 
Those results could be explained by high number of new-borns analysed in our 
research. Anamnestic data in epidemiology questionnaire about eventual hospitalisa-
tion within a year prior to beginning of the study has shown that 59% of respondents 
had been hospitalised at some clinical department, while the greatest percentage had 
been hospitalised at maternity department of the clinic (86.4%), adding to the data 
of high new-borns representation in the research. However, the German study done 
at in-hospital and out-of-hospital patients showed high prevalence of CA-MRSA 
in patients with hospitalisation data or prolonged stay at special purpose facilities 
(nursing homes) [35]. According to the definition of CDC, as well as numerous 
modifications of the definition, there are epidemiological circumstances among 
risk factors in appearance of out-of-hospital MRSA infection. Having that in mind, 
we analysed series of general prior data and the analysis followed the criteria for 
differentiating in-hospital from out-of-hospital MRSA. The data showed that only 
6% of respondents had undergone surgeries in the prior year, while 2% of positive 
respondents have used some invasive apparatus. Pets had earlier been identified as 
the source and transmitters of MRSA infections to humans in contact [36].
Analysing data of epidemiological questionnaire it shows that 10% of the 
respondents keep a pet, 3% have had documented MRSA infection before, 8% have 
had contact with MRSA carrier, while 13% practiced collective sports. Resistance 
development becomes issue of priority, and the follow up system for resistance 
measurement in relevant data, according to which antibiotics would be given by 
recommendations to lower the resistance, e.g. try to stop or slow down the develop-
ment of new resistance, has been established.
Data on resistance in the close by environment have to be basis for empirical 
therapy development, so it can be more successful in every single patient treatment, 
as well as efficient in spreading resistant types in the community.
For those reasons it is necessary to have local epidemiological data on sensitivity 
of out-of-hospital strains and specific hospital close at hand, due to variation of 
bacterial resistance level between hospital centres in different countries, between 
centres of the same country, as well as between hospital wards and departments of 
the same centre.
Staphylococcus aureus is a microorganism that developed resistance mechanisms 
to all antibiotics available for treating infections caused by staphylococci. The 
most important among those antibiotics that S. aureus developed resistance to, are 
the ones indispensable in therapy schemata for infection caused by staphylococci 
treatment and resistance mechanisms that mark antibiotics era. Penicillin as the 
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medicine of first choice for staphylococci infection treatment is almost abandoned, 
while the remaining number of isolates sensitive to penicillin activity is 20% by 
some studies [37].
According to the data extracted by isolate testing in disc – diffusion method, 
resistance to penicillin, methicillin (oxacilin) and cefoxitin showed all MRSA strains. 
Among isolates of the collection, resistance to vancomycin, linezolid, rifampicin, 
sulfamectasole – trimethoprim and fusidine acid was not shown. For vancomycin 
the sensitivity out of inhibition zone less than 14 mm in disc – diffusion method 
according to CLSI standards was not confirmed [38].
Resistance to macrolides is 68%, while to clindamycin it is significantly less and 
in amount of only 5%.
Resistance to gentamicin is 5% while to ciproflaxcin is 4%.
It is well-known that great percentage of hospital MRSA strains is resistant to 
quinolone, in total 90%. Similar results are gathered in in the research in the area of 
Republic of Croatia (91%), where the progressive test to quinolone has been fol-
lowed in the last 20 years [39].
In the world resistance phenomenon among S.aureus strains context, exact and 
early assessment of resistance is of key importance in infection caused by S.aureus 
prognosis.
Although many phenotype methods have been developed to achieve fast methi-
cillin resistance detection, lack of these methods is lessened sensitivity, which in 
the end cannot ensure appropriate and timely treatment of all patients infected 
by MRSA.
Several studies have shown that revelation of mecA gene is the “golden standard” 
method for diagnosing MRSA in microbiological laboratories [40].
However, not all laboratories, especially in transition countries such as ours 
is, have the necessary equipment and educated stuff for establishing molecular 
techniques. Thus, the need for fast, exact and economically profitable identifying 
MRSA strains by phenotype methods appeared [41].
As for disc diffusion tests for MRSA detection, sensitivity of oxacilin disc dif-
fusion test and cefoxitin disc diffusion test was 100%, while specificity was 96% 
and 98%.
Rao Venkatakrishna et al. also found high sensitivity and specificity of oxacilin 
DD and DD Cefoxitin test in MRSA detection [42].
Chromogenic surface use (ChromID) has shown 100% specificity and sensitiv-
ity. Morris et al. in their study compared chromogenic surfaces and showed sensi-
tivity for ChromID 93% [43].
In some authors’ studies [44] E-test in MRSA detection has been used as the 
golden standard and its advantages in the sense of conducting, as well as preci-
sion that approaches those of molecular methods PCR, mecA detection, have been 
proven. In our study we have also shown 100% sensitivity and specificity for E-test. 
Also, for latex agglutination test we have confirmed identical results. Ahmad has 
proven superiority of the test as the alternative method MRSA detection in his 
study [45].
After conducting phenotype methods, we have examined MRSA strains by 
molecular typing methods, and by analysis of data gathered in that way, we have 
come to interesting clinical and epidemiological findings.
With all isolates included in the research after detecting methicillin resistance 
by phenotype methods, they were subjected to molecular methods by which the 
presence mecAgene was tested. All examined isolates were positive to mecAgene, 
according to the claim that for mecAgene identification, polymerase chain reaction 
(PCR) is considered the golden standard [40].
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By method spa-typing, developed by Freney et al. [46], based on sequencing 
polymorph region X gene protein A Staphylococcus aureus (spa), we typed 29 out of 
our 100 types. We had seven various spa-types, from which the most represented 
t008 16/29 (52,2%), t1179 5/29 (17,2%), t10807 3/29 (10,3), t2674 2/29 (69%), 
t041 1/29 (3,4%), t919 1/29 (3,4%), t2187 1/29 (3,4%). If we compare it with 
relative global frequency of appearance for single spa-types by Ridom Spa Basa, 
we can notice that t008 is globally represented in 6,32%. Spa t008 is present in the 
countries such as Australia, Austria, Bulgaria, Canada, Croatia, Check Republic, 
Denmark, Estonia, Finland, Germany, Hungary, Israel, Norway, Poland, Portugal, 
Spain, Great Britain, Switzerland and Sweden. The spa type is found in sequence 
types ST-8, ST-247, ST-250 and ST-254, and placed in CC8, Northern German 
MRSA, USA300 ORSA IV and Archaic/Iberian clonal complex.
In this study t041 was represented 3,4%, while globally it is less represented with 
only 0,31% (Austria, Belgium, B&H, Croatia, Check Republic, Denmark, France, 
Germany, Hungary, Island, Ireland, Italy, Netherlands, Norway, Slovenia, Sweden 
and Switzerland), in sequence types ST-111 i ST-228, placed in CC5 and Southern 
German MRSA clonal complexes.
Representation of t919 in our study is the same as t041 (3,4%), and it appears in 
Austria, Germany, Norway and Sweden, with globally significantly less representa-
tion of 0,01%.
In our study we had four, so far unknown, spa types, and it can be explained by 
polymorph region X consisting of 24 base pairs of repeating fragments.
In our analysis the SCCmec results of typification have shown dominance of 
SCCmec type IV (86%), typical for out-of-hospital population. It is necessary to 
emphasize there is appearance trend for SCCmec type IV inside hospital popula-
tion, with the tendency of shifting SCCmec type I and dominant Iberian clone so 
far characteristic for in-hospital environment. SCCmec typing of strains included 
in our research we have proven that da SCCmec type I is seen in total of 4% strains, 
while SCCmec type V is seen in very small percentage (1%) in the examined strains. 
Valsesia et al. [47] have recently confirmed that SCCmec type IV and V was regis-
tered in examined population in the amount of 87% cases, while SCCmec type I and 
II appeared only sporadically, and SCCmec type III was completely absent in out-of-
hospital population. In our analysis we have not confirmed any case of SCCmec type 
II or III. Those results are in accordance with our results, except that SCC typing of 
strains included in the study has not shown presence of SCCmec type V types.
Previous studies have indicated that HA-MRSA infections are mainly caused by 
multiresistant strains carrying SCCmec type I, II or III, but rarely SCC mec type IV. 
On the other hand, CA-MRSA strains carrying SCCmec type IV, V or VII, are usually 
sensitive to majority of un-β-lactam antibiotics, although series of studies indicate 
spreading CA-MRSA strains in hospital centres and consequently taking place of 
traditional HA-MRSA strains [48, 49].
Our study indicates possible existence of new combinations of SCCmec frag-
ments and ccr genes evolving by recombining already described segments, and by 
completely new SCCmec types, due to genome S.aureus susceptibility to dynamic 
changes, changes of genetic parts inside the species as well as species typical for 
S.aureus. This conclusion is based on presence of 9% atypical strains.
In our collection of strains subjected to molecular analysis, all MRSA isolates 
have been tested to presence Panton-Velentine leukocidin (PVL) toxin. Number of 
PVL-positive MRSA was 23 isolates, while one isolate was atypical.
Some studies in which virulence factors with PVL of in-hospital and out-of-
hospital MRSA were examined at the same time and it is discovered that less than 
5% MRSA isolates are SCCmec I, II and III PVL positive, while 40–90% MRSA 
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SCCmec type IV contains PVL gene. [50]. CA-MRSA can represent serious  problem 
for public health due to distribution of strains with potential to produce PVL 
toxin. Presence of genes coding Panton-Valentine leukocidin is important marker 
of virulence as well as determinant of clinical consequences of infections caused 
by PVL positive types which are far heavier than PVL negative S. aureus infec-
tions. Cocchi et al. [51] in their study showed the transmission of PVL -positive 
CA-MRSA, member of Southwest Pacific clone (SWP) with epidemic capacity. The 
same study shows transmission from father with recurrent skin and subcutaneous 
tissue infections, over mother with nasal colonisation, to their child with symptoms 
of necrotising pneumonia. These data indicated that recurrent skin infections, usu-
ally not given great clinical importance, can represent serious threat in development 
of severe clinical picture of the carrier with possibility of further transmission PVL 
positive causer.
However, the role of positive MRSA strains in predicting possible severe clinical 
manifestations for the carrier still remains undefined.
CA-MRSA is linked to the production of Panton-Valentin leukocidin. Probably 
the PVL is direct virulence factor in staphylococci necrotising pneumonia [52], 
while its role in skin and soft tissues infection remains controversy.
There is epidemiological connection between MRSA and PVL, especially in the 
USA where USA300 clone dominates which is PVL positive. But counterargument 
to the attitude, at the same time confirming still undefined role of PVL as virulence 
marker in prediction of clinical infection manifestations, is the fact that there are 
several types PVL negative with the same clinical outcome that this toxin cannot 
be taken as universal marker of CA-MRSA. In the conducted analysis on 100 MRSA 
isolates, it is confirmed that 23 isolates SCCmec type IV containing gene z PVL, one 
atypical isolate while there were 76 PVL negative isolates of various SCCmec types, 
but with dominance of type IV. By examining isolates origin we established that 11 
PVL positive PVL isolates were from skin area, 8 from nasal mucosa, 2 from pustule 
smear, while others were represented by 1 PVL positive isolates from different 
corporal regions (sound conductor, wound smear).
In Great Britain, according to the National Reference Laboratory data, genes 
coding PVL are present in less than 2% of clinical isolates S. aureusa, whether MSSA 
or MRSA [52]. While PVL is currently accepted as important factor for S. aureus 
virulence, the latest research give preference to alternative virulence factors such 
as arginine catabolic mobile element (ACME), α toxin, regulatory genes coding 
expression, and newly described peptides.
PVL role is still very important, primarily due to fact it represents important 
marker in screening virulent S.aureus strains.
PFGE is genetic typing method used as means of molecular – epidemiological 
study of genetic variants of S. aureus and other numerous bacterial pathogens. For 
its highly discriminating capacity PFGE is considered golden standard for local 
epidemics of bacterial infections [53]. Combination of molecular typing methods 
(PFGE, mecA, SCCmec and MLST) with epidemiological and clinical data enable 
revelation of MRSA groups and their appearance, thus ensuring application of 
rational, appropriate, infection control measures [54]. Also, this study has enabled 
detection of MRSA groups in limited geographical area by applying methods of 
molecular typing so it can represent basis for similar studies on broad area and 
enable application of this region into European MRSA infection control network.
Comparing PFGE analysis results, by criteria of Tenover et al.(28), applying cut-
off similarities 80%, our study has shown that most of the isolates is classified into 
two larger groups, indicating clonal connection and genetic similarity of isolates. 
Dendogram contains 5 groups, marked alphabetically from A to E.
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PFGE analysis of profile isolates by computer system GelCompar isolates are 
grouped in similarity groups, inside which similarity between isolates is 80% and 
more. Thus we had results in five groups, marked alphabetically from A to E. Most 
of the isolates fell into two most numerous groups, C and D.
Group A contains 3 isolates, falling into SCCmec type IV. This group had no PVL 
positive isolates.
Group B contains four isolates, with 3 isolates belonging to SCCmec type I, while 
one belongs SCCmec type IV. This group does not have PVL positive isolates.
Group C contains 60 isolates, and represents the most numerous group in our 
PFGE analysis. All isolates of the group belong to SCCmec type IV. This group had 
28,33% (17) PVL positive isolates.
Group D has had 27 isolates, three of them atypical and the rest of them also fall 
into SCCmec type IV. In this group only two isolates were PVL positive.
Group E has had 3 isolates, belonging to SCCmec type I, IV and V. These three 
isolates were not PVL positive.
Three PFGE types are single genotypes, with two of them SCCmec IV, while one 
is atypical.
Among mostly used definitions CA-MRSA that take into account epidemiologi-
cal data, as well as genetic origin of isolates are modified definitions of the CDC. 
In cases of suspicion to CA-MRSA the first step is to eliminate any connection to 
hospitals and hospital system, because the connection for such isolates places them 
into HA-MRSA species [55].
Due to the fact it is necessary to have molecular analysis for the types aiming to 
avoid classifying MRSA strains into CA or HA MRSA strains based on epidemio-
logical data, for it might lead to possibility of crosswise mistakes.
Concerning the received results indicating presence of isolates SCCmec type IV 
and with respondents of paediatric age with positive epidemiological data of hos-
pital environment contact, traditional division to in-hospital and out-of-hospital 
MRSA is questionable and demands further revision.
Prevalence of “real” CA MRSA strains in general population broadly varies in 
different geographical areas. In meta analysis, Salgado et al. [56], showed preva-
lence in amount of 1,3% for MRSA colonisation in community. However, it must 
be pointed out that most of the people colonised by MRSA strains, had risk factors 
connected to hospitalisation.
After excluding these patients prevalence of “real” CA-MRSA colonised was 
0,2%, responding to the prevalence of the study (0,13%).
About presence of CA MRSA in Bosnia and Herzegovina there is not enough 
data. There are several genotyping isolate methods S.aureus for epidemiological 
research. However, Harbarth et al. [57] still give advantage to molecular methods of 
MRSA identification comparing to standard cultivation methods. Anyway, length 
of the procedure and the need for specialised laboratories still represents limiting 
factor for broad use of molecular analysis.
Earlier reports on CA-MRSA strains describes appearance of new strains in 
patients with the lack of traditional epidemiological risk factors for MRSA infec-
tion and/or colonisation. Those patients with CA-MRSA infection are very often 
of younger age, with minimum comorbidities and negative epidemiological data 
of hospital environment contact, comparing to patients with infections caused by 
HA-MRSA strains. Furthermore, different socio-economic characteristics related to 
CA-MRSA infections, including ethnical background and socio-economic status.
Recently, [58] however, with the growth of CA-MRSA prevalence, epidemiologi-
cal difference between these and HA-MRSA types became less defined, concerning 
numerous reports of hospital epidemics caused by CA-MRSA types.
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CA-MRSA is more often defined as cause of infections arising at hospital 
environment and infections connected to hospital environment. On the other hand, 
hospital clones are described as cause of infections in general population, indicating 
the fact that some clones are capable of successful barrier crossing between hospi-
tals and general population [59].
In spite of its clinical importance, multicentric research of the entire area of 
Bosnia and Herzegovina for prevalence and epidemiology of MRSA as the cause of 
infections in general population, has not been conducted. This imposes the neces-
sity for national monitoring of spreading and presence of these types.
6. Proposal for algorithm of treatment CA-MRSA infection
The first choice for empirical antimicrobial medication depends on MRSA 
prevalence in the community, type and severity of infection. Vancomycin should 
be prescribed in cases of severe infections [60], while microbiological data is 
available, in areas where similar infections of outpatient MRSA strains were docu-
mented. Also, it is necessary to prescribe vancomycin in cases when it is known that 
patient had been colonised by MRSA strain, or is intravenous addict or when MRSA 
infection risk factors are included. In the last ten years skin and soft tissue infec-
tions caused by CA-MRSA have reached epidemic level. The key in their treatment 
is surgical care, incision and drainage, in avoiding further tissue destruction; with 
empirical application of antibiotics modified according to microbiological find-
ings. In the areas of low prevalence CA-MRSA and in treatment of mild infections 
therapy should be started with some penicillin antibiotics resistant to penicillinase 
or the first generation of cephalosporins [61]. The carrier selection, if undertaken, 
is important in process of hospitalisation, in the open community it is impossible to 
be carried out. However, the follow up for discharged patients and control of their 
laboratory diagnostics with MRSA sensitivity examination, is more important than 
ever before. Screening can reduce MRSA incidence during hospitalisation admis-
sion process. MRSA eradication or decolonisation by topical application of mupi-
rocin or cotrimaxazole are used with various success, and some studies show that 
sulfamethoxazole-trimethoprim in available oral antibiotics has the fastest bacteria 
impact [62]. Due to fast resistance development, decolonisation of all known carri-
ers is not recommended [63].
Due to high morbidity and mortality connected to staphylococci isolates coding 
PVL, the selection of carriers and decolonisation by muciprocin is recommended 
with people having recurring abscesses despite antimicrobial therapy and their 
contacts if they have MRSA isolated in nasal vestibule.
PVL toxin and better understanding of toxin role in pathogenesis of CA-MRSA 
infections can have therapy implications. Some studies have shown that intravenous 
immunoglobulin use has benefits in positive treatment outcomes in shock therapy 
[64]. PVL neutralisation as well as other toxins by intravenous immunoglobulin is 
shown in vitro [65]. Based on the prevalence CA-MRSA of 0,13%, where none of 
the isolates caused severe infection, we estimate that empirical therapy for outpa-
tient pneumonia treatment does not need any modification by adding antibiotics 
with impact on MRSA isolate, such as vancomycin.
6.1 Detection algorithm/treatment of outpatient MRSA
Having in mind the fact that in the world and Europe number of outpatient 
MRSA increases, in diagnostic and therapeutic approach it must be taken into 
account that it is MRSA strain.
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Good sampling and choice for microbiological testing, (smear, wound aspirate 
in the case of localised infection and blood in the case of system infection), fast 
detection of MRSA in microbiological laboratory, as well as the result of sensitiv-
ity to adequate nonbetalactam antibiotics may contribute to adequate infection 
treatment and timely measure taking in infection control, aiming at reducing 
spreading of very adaptable outpatient MRSA strains in ambulances and hospital 
environment.
Diagnosis CA-MRSA infection should be considered with seriously ill young 
people who previously had had symptoms similar to influenza, pneumonia disease 
with hemoptysis symptoms, high febrility, leucopenic and and hypotensive. Those 
symptoms are signal to life threatening infection, necrotising pneumonia, and 
septic shock and, in consequence, even death outcome.
Important ways of presenting CA-MRSA infections are skin infection, with 
developing abscess, furuncle, carbuncle, without drainage infections progress 
to fasciitis, deep infections of soft tissues, after which, in case of recovery, tissue 
deformities are left.
Epidemiological definition and connection to hospital stay lose in importance 
because it is not unusual for typical CA-MRSA to cause epidemics in hospital 
wards [66].
As the first step in successful treatment the selection of suitable sample for 
microbiological testing is recommended. In cases of severe skin and subcutaneous 
tissue infections taking abscess aspirates or deep subcutaneous change will also have 
therapeutic effect.
In case of suspicion to necrotic pneumonia, blood sample usually contains cause, 
while sample from respiratory system is desirable.
For cause diagnostics of mild skin change, it is enough to take skin smear. 
Depending on sat down of infection, for sampling, standard rules of microbiologi-
cal testing apply.
For treatment outcome it is important to apply suitable antimicrobial medication 
and in the case of suspicion to MRSA infection the confirmation is of extreme value.
With application of antistaphylococci antibiotics, penicillin or cephalosporin, 
skin and subcutaneous tissue infection and fascia it is necessary to surgically treat, 
incise and debride abscess.
By standard processes of isolation and detection of S.aureus, after which the test-
ing is undertaken for isolates sensitivity to oxacilin/cephoxitin and the result due is 
in 48 hours later.
A lot better time frame is given by molecular MRSA detection based on PCR 
method. The latest PCR methods do not use amplification mecA as proof for MRSA, 
because there is a possibility of getting falsely positive results by amplification 
mecA gene coagulaze-negative staphylococci contaminating the sample. IDI-
MRSA (Infecto Diagnostic, Canada), GenoType MRSA Direct (Hain Lifescience, 
Germany), detect part of orfX gene, specific Fors. aureus and adjacent part of 
SCCmec chromosome region. In that way one PCR reaction detects MRSA in unster-
ile samples. Results are available in 24 hours.
Small number of routine laboratories in Bosnia and Herzegovina have molecular 
methods available, and they are limited to great and reference centres.
Also, the method by which MRSA diagnostics time can be significantly shorter, 
is method of latex agglutination by which PBP2a is detected (BioMerieux, France). 
Method does not require special equipment and stuff training, antigen extraction 
is simple, results relevant [67]. The method’s purpose is not for detection MRSA 
coding mecA gene, which is not prominent, because such test is falsely negative.
Detection of virulent CA-MRSA strains is also important for application of 
measures for spreading prevention during admission to hospital [68] of the patient 
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with CA MRSA infection and stay with seriously ill patients to which infection can 
have a fatal outcome. Some authors suggest selection of patients in intensive care 
units aiming at improving treatment [69]. During patient treatment with infection 
CA-MRSA, it is necessary to undertake prevention measures for spreading isolates, 
and avoid using common objects with other patients. It is considered that relatively 
great number of epidemic infections CA-MRSA is caused just by transmitting 
pathogens over objects of common use (soaps, towels…).
Transmission of out-of-hospital MRSA to laboratory employees is registered. 
Wagenvoort et al. [70] as well as to the doctor who resuscitated child with necrotic 
pneumonia caused by CA-MRSA [71] strain so it takes utmost care in treating this 
transmissible, more often described pathogen.
At this moment, MRSA strains as causes of epidemic should be typed in single 
hospitals or reference laboratories to establish whether they are CA-MRSA or 
HA-MRSA strains, for larger group of patients and stuff can represent risk that 
could demand new control strategies for CA-MRSA strains. New strategies can 
include screening the hospital stuff, enhanced follow up for cases with the infec-
tion beginning in hospital and out-of-hospital environment and vice versa. They 
would, also, include improved prevention and infection control measures in general 
population, focusing on MRSA in contaminated area [72].
Periodical examination of antimicrobial sensitivity profile of MRSA strains 
(cause of infection), in combination with representative isolate set typing of 
specific area, is useful to ensure necessary empirical therapy, having in mind that 
appearance CA-MRSA in certain parts of the world brought changes in empirical 
therapy of staphylococci infections.
Reference laboratories should periodically continue representative isolate sets 
typing to ensure adequate follow up of MRSA trends, as well as appearance of 
new types.
For complete estimation of their epidemiology, MRSA infections should be 
characterised as:
1. Caused by HA-MRSA or CA-MRSA strains.
2. Infections acquired in hospital or out of hospital environment.
3. Infections beginning in general population or in health care facilities [73].
7. Conclusions
• Prevalence Staphylococcus aureus in Sarajevo Canton is 52.5%, and methicilin 
resistance of Staphylococcus aureus is 28,7%.
• Phenotype methods in MRSA detection have high specificity and sensitivity, 
available commercially and can provide broad span application in laboratories 
as routine methods. However, they lack possibility of differentiating hospital 
from out of hospital MRSA.
• Differentiating HA and CA MRSA with epidemiological and phenotype isolate 
characteristics is possible only with molecular method application.
• MRSA strains in typing by spa-typing as follows: the most common type is 
t008 type (55.2%), than t1179 (17.2%) and t10807 (10.3%). Comparing relative 
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global frequency of single type appearance of spa-types on Ridem Spa Server, 
t008 is globally the most registered type. New spa – types discovered in this 
study are t1179, t2187, t2674 and t10807.
• Prevalence of CA MRSA in six months period of follow up in geographical area 
of Sarajevo Canton in the amount 0,13%, while prevalence of CA MRSA PVL 
positive types is 0,037%.
• From total number of typed MRSA strains, 24% of them was PVL positive. 
Most of PVL positive isolates was resistant to beta lactam and macrolide 
antibiotics.
• Comparing PFGE genetic profile MRSA isolates were classified into 5 similarity 
groups, in which two of them are dominant, groups C and D, containing 60% 
and 27% isolates. Group C had 28,33% PVL positive types, while group D had 
only 2 PVL positive isolates.
• The greatest number of MRSA isolates, 84% has SCCmec type IV speaking on 
behalf of very high representation of out of hospital MRSA. SCCmec type I is 
present in 4%, while type V was present in only 1% isolates. Atypical isolates 
were 9%, while 95,8% PVL positive isolates fell into SCCmec type IV.
• The goal of every centre for microbiological diagnostics is to improve and 
speed up diagnostics of MRSA positive patients for treatment personalisation, 
and efficient spreading prevention of CA MRSA in hospital and out of hospital 
population.
• Results of the study, conducted in the most densely populated area of Bosnia 
and Herzegovina, indicate high level of MRSA prevalence.
• Standardization of national laboratory work is necessary, clinical as well as 
public health in testing antimicrobial bacteria sensitivity, due to transfer of 
patients between institutions, communication between institutions and follow 
up resistance development. For reduction of resistance level it is necessary to 
control spending and supervising, and prescribing antibiotic medications, in 
medicine and in veterinary and food industry.
• This study emphasizes the need for national monitoring of spreading exist-
ing types, as well as emerging of new strains thus enabling inclusion of our 
country into international network of follow up for resistant bacteria.
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